Company page

Stemgen, Inc.

Stemgen, Inc. (SGNI) is a public company based in the United States, with a market capitalization of approximately $4.57 billion. The company operates in the biotechnology sector, focusing on innovative solutions and advancements in stem cell research. Stemgen aims to contribute to the development of new therapies and treatments in the medical field.